Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
June 18, 2025 01:00 ET | Source: Addex Therapeutics Geneva, Switzerland, June…
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage…
Real IQ Test Online | Quick IQ Test with Instant Results [Accurate & Legit] Special 2025 Announcement
San Francisco, CA, June 13, 2025 (GLOBE NEWSWIRE) -- Quick IQ Test…
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9…
Monolithic Power Systems Announces Second Quarter 2025 Dividend
June 13, 2025 16:01 ET | Source: Monolithic Power Systems, Inc. KIRKLAND,…
Descartes Announces Results of Annual Meeting of Shareholders
June 12, 2025 17:00 ET | Source: The Descartes Systems Group Inc…
New Survey Finds Younger Adults, More Women Seeking Treatment for Hair Loss
Manageable number of monthly hair restoration surgeries illustrates ISHRS members' hands-on, expert approach…
CJ 4DPLEX Achieves Record-Breaking May Box Office in North America
LOS ANGELES, June 6, 2025 /PRNewswire/ -- CJ 4DPLEX, the world's leading producer…
ServiceTitan Announces Fiscal First Quarter Financial Results
LOS ANGELES, June 05, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the…